Topotecan: A Review of its Efficacy in Small Cell Lung Cancer

ISSN： 0012-6667

Source： Drugs, Vol.58, Iss.3, 1999-09, pp. : 533-551

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Paclitaxel: A Pharmacoeconomic Review of its Use in Non-Small Cell Lung Cancer

By Plosker G.L. Hurst M.

PharmacoEconomics, Vol. 19, Iss. 11, 2001-11 ,pp. : 1111-1134

Adis International

Access to resources Recommend Favorite

Docetaxel: A Review of its Use in Non-Small Cell Lung Cancer

By Comer A.M. Goa K.L.

Drugs & Aging, Vol. 17, Iss. 1, 2000-07 ,pp. : 53-80

Adis International

Access to resources Recommend Favorite

A Phase I Study of Dose-Dense Topotecan Given Upfront to Standard Therapy in Patients with Small Cell Lung Cancer

By Garst Jennifer

Clinical Drug Investigation, Vol. 26, Iss. 5, 2006-01 ,pp. : 257-266

Adis International

Access to resources Recommend Favorite

Erlotinib in non-small cell lung cancer: a review

By Blackhall Fiona H Rehman Shazza Thatcher Nicholas

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 6, 2005-06 ,pp. : 995-1002

Informa Healthcare

Access to resources Recommend Favorite

Docetaxel in non-small cell lung cancer: a review

By Davies Angela M Lara Jr Primo N Mack Philip C Gandara David R

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 4, 2003-04 ,pp. : 553-565

Informa Healthcare

Access to resources Recommend Favorite